Back to Results
First PageMeta Content
Sexually transmitted diseases and infections / Antiseptics / Microbicides / Microbicides for sexually transmitted diseases / Alkaloids / Benzoates / Docetaxel / Condom / Clinical trial / Medicine / Chemistry / Health


Starpharma Interim Report and Half-year Financial Results Melbourne, Australia; 16 February 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its interim report and financial results for the half-year
Add to Reading List

Document Date: 2015-02-15 20:27:50

Open Document

File Size: 416,29 KB

Share Result on Facebook

City

Brisbane / Sydney / Melbourne / /

Company

Melbourne Australia / Ansell Limited / Lilly / Woolworths / Page 2 STARPHARMA HOLDINGS LIMITED / 3M / PricewaterhouseCoopers / Market Starpharma Holdings Limited / Page 3 STARPHARMA HOLDINGS LIMITED / 3 Starpharma Holdings Limited / AstraZeneca / Okamoto Industries / Starpharma Holdings Ltd / Declaration 6 Interim Financial Report 7 STARPHARMA HOLDINGS LTD / /

Continent

Asia / North America / Europe / /

Country

New Zealand / Japan / Australia / China / /

Currency

AUD / USD / /

/

Event

FDA Phase / Earnings Announcement / Business Partnership / /

Facility

Women’s Hospital / Alfred Hospital / /

IndustryTerm

dendrimer technology / retail / dendrimer products / sexual wellness products / drug delivery technology / retail shelves / pharmaceutical and medical uses / finance costs / agrochemical products / /

MarketIndex

ASX 300 / /

MedicalCondition

solid tumours / bacterial vaginosis / vaginal infection / cancer / important cancer / neutropenia / tumour / recurrent bacterial vaginosis / sexually transmitted infections / /

MedicalTreatment

dendrimer / dendrimers / /

Organization

Alfred Hospital / Australian Government / Austin Hospital/Olivia Newton John Cancer Centre / US Food and Drug Administration / Royal Brisbane & Women’s Hospital / FDA / Ministry of Health / /

Person

Jackie Fairley / Adama / Rebecca Wilson Mob / Nigel Baade / /

/

Position

general public pricing pressures / Chief Executive Officer / CFO and Company Secretary / Auditor / market leader / CEO / Chairman / Independent Auditor / leader in the development / leader / /

Product

LifeStyles Dual Protect™ / Taxotere / VivaGel® / DEP™ / DEP / VivaGel / in / VivaGel® Program Starpharma / /

Technology

dendrimer technology / DEP™ drug delivery technology / pharmacokinetics / drug delivery / /

URL

www.starpharma.com / /

SocialTag